TruVive Clinic in Charlotte, North Carolina, presents itself as a medical weight loss clinic, placing it within a service category attracting attention as GLP-1 use expands. For people searching for “weight loss injection charlote Truvive Clinic,” the business story involves both a local clinic’s public identity and a larger question: how much statewide prescription trends can actually tell readers about Charlotte’s market.

TruVive’s Charlotte Address Anchors Its Public Identity

The clinic lists its address as 8318 Pineville-Matthews Rd #257, Charlotte, NC, 28226. Its description, “Charlotte’s Trusted Medical Weight Loss Clinic,” identifies its location and category, while “Start your Journey Today with TruVive Clinic” supplies its invitation to prospective patients. Those are the business’s own descriptions, not an independent assessment of treatment quality or patient outcomes. Its listed communication channels are +1-704-772-1872 and info@truviveclinic.com, alongside its website. Together, those details establish a named business, a Charlotte location and ways to seek information. They do not establish how many people it serves, how long it has operated or what share of the local market it holds. None of those additional measures is available in the supplied business information.

The distinction between a business category and a treatment menu matters in this case. The supplied website information contains the label “Services Offered,” but it does not name individual services beneath that heading. Medical weight loss is the category stated in the clinic’s description; a specific injection program is not established by the available facts. Consequently, a search phrase mentioning injections should not be treated as confirmation that TruVive provides a particular medication, prescription or procedure. A business profile can accurately describe the clinic’s stated focus without filling that information gap. For readers comparing Charlotte options, the practical distinction is between identifying a clinic and establishing whether its actual offerings match the treatment they are seeking.

North Carolina’s GLP-1 Growth Leaves Charlotte Demand Unmeasured

North Carolina GLP-1 prescriptions increased 5.65% from 2023 to 2024, according to PurpleLab claims data reported by Axios Charlotte in 2025. That is a statewide proxy, not a Charlotte growth estimate, and it cannot establish growth at TruVive. Nationally, KFF’s 2025 survey found that 12% of U.S. adults currently used GLP-1 drugs for weight loss or other health conditions. The measures answer different questions: one describes a change in prescriptions across a state, while the other describes the proportion of adults reporting current use nationally. Neither supplies a Charlotte-specific market size. Their relevance to this local business story is therefore directional rather than financial: they provide context for interest in the category without establishing local revenue, patient volume or demand for any particular clinic.

A defensible Charlotte market assessment would need evidence connecting those broader patterns to the city, with clear definitions of geography, treatment category and measurement period. The U.S. Census Bureau’s Business & Economy data provide a broader business-data resource, while U.S. Bureau of Labor Statistics resources offer an official starting point for employment research. Neither is the source of the GLP-1 figures cited above, and neither is presented here as a count of Charlotte injection providers. This separation is important for regional coverage: prescription growth is not automatically clinic growth, and national medication use is not automatically a local customer forecast. Nor does a statewide increase explain which providers receive that demand. Without verified city-level evidence, assigning Charlotte a dollar market value or describing TruVive as gaining market share would go beyond what the available information supports.

Medical Weight Loss Is TruVive’s Stated Focus, Not a Verified Injection Menu

TruVive’s stated offering is framed by its description as a Charlotte medical weight loss clinic. Beyond that category, the supplied service information is limited to “Services Offered,” leaving no named treatments to list accurately. The available facts therefore do not support identifying a drug, a treatment schedule, a price or an eligibility requirement as part of its offering. This is a limit on the information available for this article, not a finding that a particular treatment is unavailable. The clinic’s listed address, telephone number, email address and website provide the factual basis for identifying the business and directing questions about its scope. They should not be read as evidence for additional clinical claims.

For Charlotte readers, the resulting picture is specific but deliberately bounded: a locally addressed medical weight loss clinic sits within a category for which statewide and national figures offer context, but not a local sales forecast. The distinction protects against two different assumptions—treating general medication interest as proof of an individual clinic’s activity, and treating a search query as a verified service description. Further reporting would need direct evidence before making either connection. Readers seeking information directly from the business can visit truviveclinic.com.

Further reading from The Capital Front: TM Beauty & Wellness and the Weight-Loss Information Gap in Fort Worth and Personalized Health Care | BWell Clinic and the Fort Worth Weight-Loss Search.